Swiss National Bank
INSP icon

Swiss National Bank’s Inspire Medical Systems INSP Stock Holding History

Swiss National Bank’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Sell
52,000
-3,500
-6% -$166K ﹤0.01% 1872
2026
Q1 		$2.86M Hold
55,500
– – ﹤0.01% 1666
2025
Q4 		$5.12M Buy
55,500
+1,100
+2% +$105K ﹤0.01% 1335
2025
Q3 		$4.04M Sell
54,400
-2,400
-4% -$243K ﹤0.01% 1445
2025
Q2 		$7.37M Sell
56,800
-1,300
-2% -$189K ﹤0.01% 1076
2025
Q1 		$9.25M Sell
58,100
-500
-0.9% -$90.5K 0.01% 939
2024
Q4 		$10.9M Buy
58,600
+600
+1% +$116K 0.01% 901
2024
Q3 		$12.2M Sell
58,000
-1,600
-3% -$278K 0.01% 841
2024
Q2 		$7.98M Buy
59,600
+1,300
+2% +$246K 0.01% 1001
2024
Q1 		$12.5M Buy
58,300
+500
+0.9% +$98K 0.01% 818
2023
Q4 		$11.8M Sell
57,800
-6,400
-10% -$1.04M 0.01% 816
2023
Q3 		$12.7M Buy
64,200
+700
+1% +$177K 0.01% 780
2023
Q2 		$20.6M Buy
63,500
+1,200
+2% +$343K 0.01% 632
2023
Q1 		$14.6M Sell
62,300
-7,200
-10% -$1.82M 0.01% 702
2022
Q4 		$17.5M Buy
69,500
+4,100
+6% +$874K 0.01% 673
2022
Q3 		$11.6M Buy
65,400
+700
+1% +$141K 0.01% 809
2022
Q2 		$11.8M Hold
64,700
– – 0.01% 823
2022
Q1 		$16.6M Buy
64,700
+4,700
+8% +$1.07M 0.01% 764
2021
Q4 		$13.8M Sell
60,000
-100
-0.2% -$24.4K 0.01% 839
2021
Q3 		$14M Buy
60,100
+300
+0.5% +$62.6K 0.01% 821
2021
Q2 		$11.6M Buy
59,800
+4,400
+8% +$873K 0.01% 938
2021
Q1 		$11.5M Buy
55,400
+900
+2% +$191K 0.01% 929
2020
Q4 		$10.3M Buy
54,500
+100
+0.2% +$16.4K 0.01% 915
2020
Q3 		$7.02M Buy
54,400
+5,900
+12% +$650K 0.01% 984
2020
Q2 		$4.22M Buy
48,500
+25,200
+108% +$1.94M ﹤0.01% 1243
2020
Q1 		$1.41M Buy
23,300
+400
+2% +$29.6K ﹤0.01% 1657
2019
Q4 		$1.7M Buy
22,900
+600
+3% +$38.6K ﹤0.01% 1824
2019
Q3 		$1.36M Buy
22,300
+500
+2% +$32.9K ﹤0.01% 1891
2019
Q2 		$1.32M Buy
21,800
+10,100
+86% +$544K ﹤0.01% 1962
2019
Q1 		$664K Buy
11,700
+400
+4% +$21.6K ﹤0.01% 2281
2018
Q4 		$477K Buy
+11,300
New +$480K ﹤0.01% 2369

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Swiss National Bank's INSP Position: Q2 2026 in Review

Swiss National Bank reduced its Inspire Medical Systems (INSP) stake by 6.3% in Q2 2026, selling an estimated $166K and leaving 52,000 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

Swiss National Bank first reported a position in INSP in Q4 2018 and has held it in 31 quarters since. The position peaked at $20.6M in Q2 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Swiss National Bank held 52,000 shares of Inspire Medical Systems worth $2.32M as of Q2 2026.
  • Swiss National Bank sold 3,500 Inspire Medical Systems shares in Q2 2026, an estimated $166K.
  • Inspire Medical Systems made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1872 holding.
  • Swiss National Bank first reported a position in Inspire Medical Systems in Q4 2018 and has held it in 31 quarters since.
  • Swiss National Bank's Inspire Medical Systems position peaked at $20.6M in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.